Harijati Versmessen

Summary

Affiliation: Universitair Ziekenhuis Brussel
Country: Belgium

Publications

  1. pmc A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
    Darius Norkus
    Department of Radiotherapy, Institute of Oncology, Vilnius University, Vilnius, Lithuania
    Radiat Oncol 8:206. 2013
  2. pmc Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy
    Harijati Versmessen
    Department of Radiation Oncology, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
    BMC Cancer 12:495. 2012
  3. pmc Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy
    Nele Adriaenssens
    Breast Clinic, Oncologic Surgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    World J Surg Oncol 10:86. 2012
  4. pmc Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy
    Nele Adriaenssens
    Breast Clinic, Oncological Surgery, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    Breast Cancer (Auckl) 6:79-93. 2012
  5. ncbi request reprint Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial
    Samuel Bral
    Department of Radiotherapy, University Hospital Brussels, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 80:1343-9. 2011
  6. ncbi request reprint Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy
    Samuel Bral
    Department of Radiation Oncology, Oncology Center, Universitair Ziekenhuis Brussel UZB, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 77:1352-9. 2010

Collaborators

Detail Information

Publications6

  1. pmc A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
    Darius Norkus
    Department of Radiotherapy, Institute of Oncology, Vilnius University, Vilnius, Lithuania
    Radiat Oncol 8:206. 2013
    ..Here, we report on acute toxicity and quality of life (QOL) for the first 124 randomized patients...
  2. pmc Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy
    Harijati Versmessen
    Department of Radiation Oncology, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
    BMC Cancer 12:495. 2012
    ..Tomotherapy uses an integrated computed tomography scanner to improve treatment accuracy, aiming to reduce the adverse effects of radiotherapy...
  3. pmc Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy
    Nele Adriaenssens
    Breast Clinic, Oncologic Surgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    World J Surg Oncol 10:86. 2012
    ..We evaluated the risk factors associated with SA and the relationship of SA with ipsilateral shoulder/arm morbidity in a series of patients enrolled in a trial of post-surgery radiotherapy (RT)...
  4. pmc Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy
    Nele Adriaenssens
    Breast Clinic, Oncological Surgery, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    Breast Cancer (Auckl) 6:79-93. 2012
    ..Shoulder/arm morbidity is a common complication of breast cancer surgery and radiotherapy (RT), but little is known about acute contralateral morbidity...
  5. ncbi request reprint Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial
    Samuel Bral
    Department of Radiotherapy, University Hospital Brussels, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 80:1343-9. 2011
    ..Validation of a prospective, risk-adapted strategy for early-stage non-small-cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT)...
  6. ncbi request reprint Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy
    Samuel Bral
    Department of Radiation Oncology, Oncology Center, Universitair Ziekenhuis Brussel UZB, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 77:1352-9. 2010
    ..To prospectively assess the feasibility, toxicity, and local control of a class solution protocol of moderately hypofractionated tomotherapy in Stage III, inoperable, locally advanced non-small-cell lung cancer patients...